Domain-First AI Architect
I bring AI-native thinking from research to production — wherever hard science meets the real world.
I started at the intersection of biology and AI during my PhD, where I learned that the hardest part of applied AI isn't the model — it's understanding the domain deeply enough to ask the right question.
At HITS, I put that belief into practice. I led the bio-domain research behind HyperLab, an AI-powered drug discovery platform, and owned OmicsHorizon — Korea's first commercially deployed AI agent for biological data analysis. From research to architecture to product launch, I experienced the full lifecycle of turning deep science into a shipping product.
Now I'm bringing that same approach to semiconductor manufacturing — applying AI agents and data-driven methods to optimize processes at scale. The domain changes; the mindset doesn't. I treat AI not as a hammer looking for nails, but as a lens to rethink how complex physical systems are understood and operated.
I'm most energized when I can go end-to-end — from asking the right question, to building the solution, to shipping it.
R&D Process Engineer, NAND C&C
Applying AI-native approaches to semiconductor process development and optimization.
AI Researcher
Led bio-AI research for HyperLab, a drug discovery platform; built and shipped OmicsHorizon — Korea's first commercial AI agent for biological data analysis.
Korea's first commercial Bio AI Agent platform
AI Drug Discovery Platform
Feel free to reach out for collaborations or discussions.
hyeok797@gmail.com